The Crosstalk between Gut Microbiota and White Adipose Tissue Mitochondria in Obesity

Abstract

Adipose tissue (AT) dysregulation is a key process in the pathophysiology of obesity and its cardiometabolic complications, but even if a growing body of evidence has been collected over recent decades, the underlying molecular basis of adiposopathy remains to be fully understood. In this context, mitochondria, the intracellular organelles that orchestrate energy production and undergo highly dynamic adaptive changes in response to changing environments, have emerged as crucial regulators of both white (WAT) and brown adipose tissue (BAT) metabolism and function. Given that the gut microbiota and its metabolites are able to regulate host metabolism, adipogenesis, WAT inflammation, and thermogenesis, we hypothesize that their frequently observed dysregulation in obesity could affect AT metabolism by exerting direct and indirect effects on AT mitochondria. By collecting and revising the current evidence on the connections between gut microbiota and AT mitochondria in obesity, we gained insights into the molecular biology of their hitherto largely unexplored crosstalk, tracing how gut microbiota may regulate AT mitochondrial function.

Female obesity: clinical and psychological assessment toward the best treatment

“…Obesity-associated microbiota influences the efficiency of calorie uptake from ingested foods, host energy harvesting, insulin resistance, hepatic metabolism, inflammation, as well as central regulation of appetite and satiety and food reward signalling, which all have crucial roles in obesity. Moreover, some strains of bacteria and their metabolic products might directly target the brain by vagal afferent innervation or immune-neuroendocrine mechanisms (36,37).…”

Targeting the Adipose Tissue–Liver–Gut Microbiota Crosstalk to Cure MASLD

“…In the review by Rinninella et al, a complete taxonomic gut microbiota composition is reported, with an exhaustive description of the genera of the above-mentioned classes [12]. Along the GI tract, there is a great variability of microbiota concentration, with a low presence in the upper intestine (10-10 3 cells/g) and a great abundance in the colon (10 11 -10 12 cells/g), representing about 0.2 kg of weight in a healthy adult man of 70 kg [15].…”

Effects of Natural Alternative Sweeteners on Metabolic Diseases

“…In May 2022, the World Health Organization published a report on the status of the obesity pandemic in Europe, which revealed that approximately 60% of individuals residing in the region are either overweight or obese [ 2 ]. Obesity can result in metabolic dysregulation, which can interfere with the proper functioning of key metabolic organs, including the liver, adipose tissue, pancreas, muscles, and intestines [ 3 4 5 ]. Studies on the distribution and determinants of diseases in populations have shown that there is a connection between high body mass index (BMI) and various chronic conditions such as non-alcoholic fatty liver disease (NAFLD) [ 6 ], cardiovascular disease [ 7 8 ], diabetes [ 7 9 ], multiple cancers [ 10 11 12 ], musculoskeletal diseases [ 13 14 ], and chronic kidney disease [ 7 ].…”